CELZ
Creative Medical Technology Holdings, Inc.NASDAQHealthcare$2.05+3.19%ClosedMarket Cap: $5.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.68
P/S
920.43
EV/EBITDA
0.28
DCF Value
$2.95
FCF Yield
-106.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-964.8%
Operating Margin
-102380.2%
Net Margin
-99916.8%
ROE
-85.7%
ROA
-76.8%
ROIC
-81.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.0K | -964.8% | $-1.9M | $-1.9M | $-0.73 | — |
| FY 2025 | $6.0K | -1992.0% | $-6.1M | $-6.0M | $-2.52 | — |
| Q3 2025 | $0.00 | NaN% | $-1.3M | $-1.2M | $-0.48 | — |
| Q2 2025 | $0.00 | -Infinity% | $-1.3M | $-1.2M | $-0.48 | — |
| Q1 2025 | $3.0K | 60.0% | $-1.7M | $-1.6M | $-0.83 | — |
| Q4 2024 | $3.0K | 60.0% | $-1.9M | $-1.9M | $-1.12 | — |
| FY 2024 | $11.0K | 60.0% | $-5.7M | $-5.5M | $-3.71 | — |
| Q3 2024 | $0.00 | -Infinity% | $-1.1M | $-1.0M | $-0.75 | — |
| Q2 2024 | $8.0K | 60.0% | $-1.6M | $-1.6M | $-1.11 | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.1M | $-1.0M | $-0.73 | — |
| Q4 2023 | $3.0K | -790.7% | $-1.8M | $-1.7M | $-1.21 | — |
| FY 2023 | $9.0K | 60.0% | $-5.6M | $-5.3M | $-3.76 | — |